BackPascal Biosciences Overview

Pascal Biosciences Receivables

Track Pascal Biosciences's receivables ($200K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$203000.00
↓ 16.70% YoYΔ $-40704.00 vs prior year quarter

Peer trimmed avg / median

Loading

Pascal Biosciences Receivables History

Loading

Pascal Biosciences vs. peers: Receivables Comparison

Loading

Pascal Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pascal Biosciences (PSCBF) FAQ

Pascal Biosciences's receivables stands at $200K as of May 2026. That compares with $240K in the prior-year period — down 16.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Pascal Biosciences reported $200K in receivables versus $240K a year earlier — a 16.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $240K in the prior-year period — down 16.7% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Pascal Biosciences's receivables evolved across reporting periods, while the comparison chart places PSCBF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.